Page last updated: 2024-09-03

n,n-dimethylarginine and Dyslipidemia

n,n-dimethylarginine has been researched along with Dyslipidemia in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (33.33)29.6817
2010's7 (58.33)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Baião, DDS; da Silva, DVT; Paschoalin, VMF; Trindade, LR1
Singh, SA; Srinivasan, K; Venkatesh, R1
Cholewka, A; Furmański, M; Owczarek, AJ; Stanek, A; Strzelczyk, JK; Wielkoszyński, T; Zalejska-Fiolka, J1
Ercan, M; Firtina, S; Konukoglu, D1
Atarashi, H; Kohashi, K; Kosugi, M; Kusama, Y; Morisawa, T; Nakagomi, A; Saiki, Y; Shimizu, W1
Cai, A; Li, D; Liang, Q; Mai, W; Mai, Z; Qiu, R; Xu, R; Zeng, F; Zheng, D1
Adachi, H; Fujiwara, N; Kawagoe, Y; Nakamura, T; Okuda, S; Sato, E; Suzuki, T; Ueda, S; Ueda, Y; Yamagishi, S1
Adachi, H; Fujiwara, N; Fukami, K; Kawagoe, Y; Matsui, T; Nakamura, T; Okuda, S; Sato, E; Suzuki, T; Takeuchi, M; Ueda, S; Ueda, Y; Yamada, S; Yamagishi, S1
Fujiwara, N; Fukami, K; Kawagoe, Y; Nakamura, T; Okuda, S; Sato, E; Suzuki, T; Ueda, S; Ueda, Y; Yamagishi, S1
Abe, A; Katayama, Y; Katsura, K; Nagayama, H; Nishiyama, Y; Otsuka, T; Ueda, M1
Biberoğlu, G; Bideci, A; Camurdan, MO; Cinaz, P; Demirel, F; Hasanoğlu, A; Yesilkaya, E1
Lipman, ML; Mann, JF; Schiffrin, EL1

Reviews

2 review(s) available for n,n-dimethylarginine and Dyslipidemia

ArticleYear
Increasing the Power of Polyphenols through Nanoencapsulation for Adjuvant Therapy against Cardiovascular Diseases.
    Molecules (Basel, Switzerland), 2021, Jul-30, Volume: 26, Issue:15

    Topics: Antioxidant Response Elements; Antioxidants; Arginine; Cardiotonic Agents; Diabetes Mellitus; Drug Carriers; Drug Compounding; Dyslipidemias; Gene Expression Regulation; Humans; Hypertension; Myocardial Ischemia; Nanocapsules; NF-E2-Related Factor 2; Nitric Oxide; Oxidative Stress; Polyphenols; Signal Transduction

2021
Chronic kidney disease: effects on the cardiovascular system.
    Circulation, 2007, Jul-03, Volume: 116, Issue:1

    Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Atherosclerosis; Biomarkers; Bone Resorption; Calcinosis; Calcium; Cardiovascular Diseases; Chronic Disease; Clinical Trials as Topic; Cohort Studies; Creatinine; Cystatin C; Cystatins; Diabetes Complications; Disease Progression; Dogs; Dyslipidemias; Endothelium, Vascular; Glomerular Filtration Rate; Humans; Hypertension, Renal; Inflammation Mediators; Kidney Diseases; Oxidative Stress; Phosphates; Renin-Angiotensin System; Risk Factors

2007

Trials

1 trial(s) available for n,n-dimethylarginine and Dyslipidemia

ArticleYear
Co-administration of ezetimibe enhances proteinuria-lowering effects of pitavastatin in chronic kidney disease patients partly via a cholesterol-independent manner.
    Pharmacological research, 2010, Volume: 61, Issue:1

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Anticholesteremic Agents; Arginine; Azetidines; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Deoxyguanosine; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Fatty Acid-Binding Proteins; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Male; Middle Aged; Proteinuria; Quinolines; Severity of Illness Index; Treatment Outcome; Triglycerides

2010

Other Studies

9 other study(ies) available for n,n-dimethylarginine and Dyslipidemia

ArticleYear
Effect of arginine:lysine and glycine:methionine intake ratios on dyslipidemia and selected biomarkers implicated in cardiovascular disease: A study with hypercholesterolemic rats.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 91

    Topics: Administration, Oral; Amino Acids; Animals; Arginine; Biomarkers; Body Weight; Cardiovascular Diseases; Dyslipidemias; Glycine; Homocysteine; Hypercholesterolemia; Lipids; Liver; Lysine; Male; Methionine; Nitric Oxide; Organ Size; Rats, Wistar

2017
Oxysterols Increase Inflammation, Lipid Marker Levels and Reflect Accelerated Endothelial Dysfunction in Experimental Animals.
    Mediators of inflammation, 2018, Volume: 2018

    Topics: Animals; Arginine; Aryldialkylphosphatase; C-Reactive Protein; Cholesterol; Dyslipidemias; Homocysteine; Hypercholesterolemia; Inflammation; Interleukin-6; Lipids; Male; Oxysterols; Rabbits; Tumor Necrosis Factor-alpha

2018
Comparison of plasma viscosity as a marker of endothelial dysfunction with nitric oxide and asymmetric dimethylarginine in subjects with dyslipidemia.
    Clinical hemorheology and microcirculation, 2014, Volume: 57, Issue:4

    Topics: Adult; Aged; Arginine; Atherosclerosis; Biomarkers; Blood Viscosity; Dyslipidemias; Endothelium, Vascular; Female; Humans; Lipoproteins, LDL; Male; Middle Aged; Nitric Oxide

2014
Effects of eicosapentaenoic acid on the levels of inflammatory markers, cardiac function and long-term prognosis in chronic heart failure patients with dyslipidemia.
    Journal of atherosclerosis and thrombosis, 2014, Volume: 21, Issue:7

    Topics: Aged; Arginine; Biomarkers; Chemokine CCL2; Chromatography, High Pressure Liquid; Chronic Disease; Dyslipidemias; Eicosapentaenoic Acid; Female; Follow-Up Studies; Heart Failure; Humans; Inflammation Mediators; Male; Prognosis; Survival Rate; Ventricular Function, Left

2014
Atorvastatin protects endothelium by decreasing asymmetric dimethylarginine in dyslipidemia rats.
    Lipids in health and disease, 2015, May-02, Volume: 14

    Topics: Animals; Arginine; Atorvastatin; Blood Glucose; Cholesterol; Cholesterol, HDL; Creatine Kinase; Dyslipidemias; Endothelium, Vascular; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardium; Nitric Oxide; Rats; Rats, Sprague-Dawley; Triglycerides

2015
Ezetimibe decreases serum levels of asymmetric dimethylarginine (ADMA) and ameliorates renal injury in non-diabetic chronic kidney disease patients in a cholesterol-independent manner.
    Pharmacological research, 2009, Volume: 60, Issue:6

    Topics: Adult; Arginine; Azetidines; Cholesterol; Dyslipidemias; Ezetimibe; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged

2009
Positive association of serum levels of advanced glycation end products and high mobility group box-1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients.
    Metabolism: clinical and experimental, 2009, Volume: 58, Issue:11

    Topics: Adult; Arginine; Cross-Sectional Studies; Dyslipidemias; Female; Glycation End Products, Advanced; Hemodynamics; HMGB1 Protein; Humans; Kidney Failure, Chronic; Male; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Regression Analysis

2009
Asymmetric dimethylarginine (ADMA) as a possible risk marker for ischemic stroke.
    Journal of the neurological sciences, 2010, Mar-15, Volume: 290, Issue:1-2

    Topics: Age Factors; Aged; Arginine; Biomarkers; Blood Glucose; Brain Ischemia; Cholesterol, LDL; Dyslipidemias; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Predictive Value of Tests; Risk Factors; Sensitivity and Specificity; Stroke; Up-Regulation

2010
Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome.
    Clinical endocrinology, 2007, Volume: 67, Issue:1

    Topics: Adolescent; Apolipoproteins B; Arginine; Biomarkers; Case-Control Studies; Cholesterol; Cholesterol, LDL; Dyslipidemias; Female; Humans; Leptin; Lipoprotein(a); Lipoproteins, LDL; Lipoproteins, VLDL; Multivariate Analysis; Obesity; Polycystic Ovary Syndrome; Triglycerides

2007